InMed Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
21 Feb 24 | BuyUS$14,625 | Andrew Hull | Individual | 37,500 | US$0.39 | |
20 Feb 24 | BuyUS$14,922 | Eric Adams | Individual | 41,600 | US$0.36 |
Insider Trading Volume
Insider Buying: INM insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 87,177 | 1.44% |
Individual Insiders | 94,712 | 1.56% |
Hedge Funds | 1,118,148 | 18.5% |
General Public | 4,756,933 | 78.5% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 82%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
606,214 | US$152.8k | 0% | no data | |||
511,934 | US$129.0k | 0% | 0.79% | |||
43,959 | US$11.1k | 1,390% | no data | |||
38,900 | US$9.8k | 0% | no data | |||
38,258 | US$9.6k | 4,950% | no data | |||
34,009 | US$8.6k | 0% | no data | |||
12,894 | US$3.2k | 0% | no data | |||
12,183 | US$3.1k | 0% | no data | |||
556 | US$140.1 | 0.18% | no data | |||
240 | US$60.4 | 0% | no data | |||
200 | US$50.4 | 0% | no data | |||
200 | US$50.4 | 0% | no data | |||
100 | US$25.2 | 0% | no data | |||
85 | US$21.4 | 0% | no data | |||
80 | US$20.1 | 0% | no data | |||
59 | US$14.8 | 0% | no data | |||
51 | US$12.8 | 0% | no data | |||
27 | US$6.9 | -29% | no data | |||
21 | US$5.3 | 0% | no data | |||
21 | US$5.3 | 0% | no data | |||
14 | US$3.5 | 0% | no data | |||
12 | US$3.1 | -40% | no data | |||
11 | US$2.7 | -57.7% | no data | |||
6 | US$1.5 | 0% | no data | |||
2 | US$0.5 | 0% | no data |